Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) subsidiary MindWave Innovations Inc. is the focus of the latest CryptoCurrencyWire Audio Production, released by IBN. In an interview with IBN’s Carmel Fisher, MindWave CEO Dr. Vin Menon outlined the development of MindChain, an institutional blockchain platform that combines digital asset infrastructure with insurance protection. The podcast, part of CryptoCurrencyWire’s ongoing coverage of the blockchain and cryptocurrency sector, provides insight into how the subsidiary aims to build enterprise blockchain ecosystems across multiple industries.
Menon described initiatives spanning climate technology, media and advertising, and insurance. These include a ClimateTech partnership with AQUAE Impact, an AdTech agreement involving a Nasdaq-listed company, and an InsurTech ecosystem under development to integrate insurance claims and reinsurance processing into smart contracts. The discussion highlights MindWave’s strategy to position MindChain as a Layer 2 network tailored for regulated financial services, real-world asset tokenization, and enterprise applications.
The interview also detailed MindWave’s enterprise revenue model, which comprises one-time licensing fees, participation in digital assets, and recurring maintenance agreements. According to Menon, the subsidiary aims to generate revenue by helping businesses establish and operate blockchain-based ecosystems while providing ongoing infrastructure management. This approach could appeal to companies seeking to adopt blockchain without building internal expertise, potentially accelerating institutional adoption of digital assets.
For Apimeds Pharmaceuticals, the subsidiary’s progress may offer a pathway to diversify beyond pharmaceuticals, though the company remains primarily focused on its core business. The podcast explores broader themes of institutional adoption, enterprise partnerships, and long-term growth opportunities. Investors seeking the latest news and updates relating to APUS can visit the company’s newsroom at https://ibn.fm/APUS. The full press release is available at https://ibn.fm/eInJc.
The production was released by IBN, one of 75+ brands within the Dynamic Brand Portfolio @ IBN. IBN delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution to millions of followers, and a full array of tailored corporate communications solutions.
The announcement matters because it sheds light on how a small pharmaceutical company is branching into blockchain infrastructure through a subsidiary. MindWave’s focus on regulated industries and real-world asset tokenization could position it in a growing niche where traditional finance meets decentralized technology. The company’s Transparency Center, which publishes contributions, allocations, and governance results, may also appeal to institutional investors concerned about accountability. As blockchain adoption continues to evolve, MindWave’s enterprise model—combining licensing, digital asset participation, and maintenance—could serve as a template for other firms seeking recurring revenue from blockchain services.
